The company said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.
Tag Archive for: Diabetes
Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts are betting on a 2027 list that will include Novo Nordisk’s blockbuster Ozempic for diabetes and have a limited impact on Big Pharma.
Eli Lilly’s weight-loss drug cut the risk of developing type 2 diabetes by 94% in pre-diabetic adults who were overweight or obese after three years of weekly injections, the company disclosed in a statement on Tuesday.
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
By the end of the year, Novo Nordisk intends to make a regulatory filing for the combination of its icodec and semaglutide, keeping its once-weekly insulin program afloat.
The new insulin production facility is at Sanofi’s existing site in Frankfurt, where it makes insulin brand Lantus, the company said on Thursday.
Adding to growing evidence of its benefits beyond glucose control and weight loss, Novo Nordisk’s Ozempic could also potentially help diabetics quit smoking, according to new research.
The company has spent billions to boost production – mostly in its native Denmark and in the United States – as it has struggled to meet huge demand.
Democratic U.S. Senate aides will meet with Novo Nordisk executives on Tuesday to discuss fallout from its decision to stop selling one of its long-acting insulins in the country, two sources familiar with the meeting told Reuters.
In its Complete Response Letter, the regulator made “requests” related to the drug candidate’s manufacturing process, Novo said in its announcement. The FDA also raised concerns related to the use of insulin icodec in type 1 diabetes (T1D).